LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

Home・Akcijų sąrašas・Microbot Medical Inc

Microbot Medical Inc

Uždarymo kaina

2.14 2.39

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.07

Max

2.18

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-77K -3.6M
Darbuotojai	20
EBITDA	-79K -3.6M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+257.14% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-23

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	5.4M 146M
Ankstesnė atidarymo kaina	-0.25
Ankstesnė uždarymo kaina	2.14

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

2.52 / 2.57 Palaikymas ir pasipriešinimas

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-19 23:47; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-02-19 23:47; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

2026-02-19 23:39; UTC

Įsigijimai, susijungimai, perėmimai

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

2026-02-19 23:38; UTC

Uždarbis

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

2026-02-19 23:38; UTC

Uždarbis

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

2026-02-19 23:38; UTC

Uždarbis

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

2026-02-19 23:37; UTC

Rinkos pokalbiai

Gold Edges Lower on Possible Position Adjustment -- Market Talk

2026-02-19 23:34; UTC

Uždarbis

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

2026-02-19 23:34; UTC

Uždarbis

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

2026-02-19 23:33; UTC

Uždarbis

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

2026-02-19 23:33; UTC

Uždarbis

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

2026-02-19 22:13; UTC

Rinkos pokalbiai

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

2026-02-19 22:08; UTC

Uždarbis

Fairfax Financial 4Q Rev $8.11B >FFH.T

2026-02-19 22:07; UTC

Uždarbis

Eldorado Gold 4Q EPS $1.19 >ELD.T

2026-02-19 22:06; UTC

Uždarbis

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

2026-02-19 22:05; UTC

Uždarbis

Eldorado Gold 4Q Adj EPS 63c >ELD.T

2026-02-19 22:05; UTC

Uždarbis

Eldorado Gold 4Q Rev $577.2M >ELD.T

2026-02-19 22:04; UTC

Uždarbis

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

2026-02-19 22:04; UTC

Uždarbis

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

2026-02-19 21:50; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2026-02-19 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-19 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-02-19 21:43; UTC

Uždarbis

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

2026-02-19 21:42; UTC

Įsigijimai, susijungimai, perėmimai

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

2026-02-19 21:42; UTC

Uždarbis

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

2026-02-19 21:41; UTC

Uždarbis

Correct: St Barbara 1H Net Loss A$249,000

2026-02-19 21:40; UTC

Uždarbis

St Barbara 1H Net Loss A$249 Million

2026-02-19 21:39; UTC

Uždarbis

Perseus Mining Reaffirms FY26 Production, AISC Guidance

2026-02-19 21:37; UTC

Uždarbis

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

2026-02-19 21:37; UTC

Uždarbis

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

257.14% į viršų

12 mėnesių prognozė

Vidutinis 7.5 USD 257.14%

Aukščiausias 12 USD

Žemiausias 5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Microbot Medical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.